Stay up to date on recent advances in oncology nursing and patient care.
Subcutaneous Daratumumab Reduces Smoldering Myeloma Progression
Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies
Venetoclax Combo Did Not Increase OS in Intermediate/High-Risk MDS
Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL
How to Manage ICANS in Patients With Hematologic Cancers
Managing CRS in Hematologic Cancers: A Nursing Perspective
Nurses Lead Toxicity Monitoring in Indolent Lymphoma Care
Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC
Lutetium Lu 177 Dotatate Brings Partial Response in Metastatic BP-NETs
Safety Management With Amivantamab Plus Lazertinib in NSCLC
